Differences in influenza and pneumococcal vaccination coverage according to chronic respiratory diseases during the COVID-19 pandemic in France in France: a nationwide cohort study using the French National Health Data System
Objectives
To assess pneumococcus and influenza vaccine coverage and associated characteristics in patients with chronic respiratory diseases (COPD, lung cancer, interstitial lung disease, cystic fibrosis [CF], non-cystic fibrosis bronchiectasis, pulmonary hypertension, and severe asthma under continuous treatment)
Conclusion
Primary pneumococcal sequence completion among French adults with CRDs was only 16% for pneumococcal vaccination over the 2013–2020 period, and seasonal influenza coverage was 56.8% for the 2020–2021 season, which is below the EU target of 75%. Older age and comorbidities were associated with higher uptake for influenza but not pneumococcal vaccination. In this high-risk population, post-pandemic monitoring of vaccination uptake is needed as well as strategies such as simplified vaccination schedules, expanded vaccinator roles, and systematic integration of vaccination into care pathways to improve protection.